Live feed11:49:05·1619dINSIDERFilingvia QuantisnowSEC Form 4: Biotech Target N V bought $807,180 worth of shares (200,000 units at $4.04), increasing direct ownership by 2% to 10,992,003 unitsByQuantisnow·Wall Street's wire, on your screen.MTEM· Molecular Templates Inc.Health CareOriginal source